Search results
Results From The WOW.Com Content Network
President Duterte during a meeting with members of the IATF-EID at the Matina Enclaves in Davao City in June 2020. The COVID-19 Immunization Program Management Organizational Structure was formed on October 26, 2020, to facilitate the distribution of COVID-19 vaccines in the Philippines, however this was replaced by a vaccine cluster within the Inter-Agency Task Force for the Management of ...
Main page; Contents; Current events; Random article; About Wikipedia; Contact us; Help; Learn to edit; Community portal; Recent changes; Upload file
The COVID-19 pandemic in the Philippines was a part of the worldwide pandemic of coronavirus disease 2019 caused by severe acute respiratory syndrome coronavirus 2 . [4] As of January 21, 2025, there have been 4,173,631 [ 1 ] reported cases, and 66,864 [ 1 ] reported deaths, the fifth highest in Southeast Asia , behind Vietnam , Indonesia ...
The COVID-19 pandemic in Metro Manila was a part of the worldwide pandemic of coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). The virus reached Metro Manila on January 30, 2020, when the first case of COVID-19 in the Philippines was confirmed in Manila. Metro Manila is the worst ...
The Bayanihan to Recover as One Act, also known as Bayanihan 2, [1] and officially designated as Republic Act No. 11494, is a law in the Philippines that was enacted in September 2020 granting the President additional authority to combat the COVID-19 pandemic in the Philippines.
The U.S. Defense Department admitted that it spread propaganda in the Philippines aimed at disparaging China’s Sinovac vaccine during the COVID-19 pandemic, according to a June 25 document cited ...
Timeline of the COVID-19 pandemic in the Philippines (2022) Index of articles associated with the same name This set index article includes a list of related items that share the same name (or similar names).
This page was last edited on 11 February 2023, at 06:42 (UTC).; Text is available under the Creative Commons Attribution-ShareAlike 4.0 License; additional terms may apply.